SOHO State of the Art Updates and Next Questions: Updates on BTK Inhibitors for the Treatment of Chronic Lymphocytic Leukemia
Saumya Easaw, Shawyon Ezzati, Catherine C. Coombs
Topics & Concepts
IbrutinibBruton's tyrosine kinaseChronic lymphocytic leukemiaTolerabilityMedicineChemoimmunotherapyCancer researchPharmacologyLeukemiaTyrosine kinaseImmunologyInternal medicineAdverse effectReceptorChronic Lymphocytic Leukemia ResearchImmunodeficiency and Autoimmune DisordersLymphoma Diagnosis and Treatment